Schonfeld Strategic Advisors LLC Biogen Inc. Call Options Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $6.2 Million - $7.81 Million	32,000 Added 106.67%	62,000 $13.1 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $2.36 Million - $3.56 Million	10,000 Added 50.0%	30,000 $7.35 Million
Q3 2020 Nov 19, 2020	SELL	$264.77 - $305.71 $524 Million - $605 Million	-1,980,000 Reduced 99.0%	20,000 $5.67 Million
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $530 Million - $611 Million	2,000,000 New	2,000,000 $5.67 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.